Literature DB >> 19300126

Intestinal mucus barrier in normal and inflamed colon.

Enrico Stefano Corazziari1.   

Abstract

Intestinal bacteria are usually regarded as harmless commensals in healthy intestine but are pathogens, if these invade the tissues. The mucus gel separates the luminal bacteria from the epithelial surface throughout the colon in healthy individuals. This viscoelastic mucus gel is protective against adhesion and invasion by microorganisms, bacterial toxins, and antigens. The mucus viscosity increases progressively toward the distal colon, separating bacteria selectively in the proximal colon and completely in the distal colon. Mucus in normal subjects is usually intact and devoid of bacteria, by contrast mucus barrier is broken and penetrated by bacteria and inflammatory cells in patients with colonic inflammation. The immune inclusion hypothesis postulates that the host mucosa maintains an adherent bacterial biofilm that develops immune tolerance with specific immune mechanisms. The bacterial biofilm, growing in the mucus matrix, would prevent contact of pathogenic bacteria with the intestinal mucosal wall. On the contrary, recent evidence indicates that bacteria are absent in mucus from healthy individuals and present in mucus from patients with inflammatory bowel disease. In inflammatory bowel disease alteration in the types of mucins or, alternatively, the altered mucus layer as a response to inflammation contributes to the underlying pathology by affecting the mucus barrier function.

Entities:  

Mesh:

Year:  2009        PMID: 19300126     DOI: 10.1097/MPG.0b013e3181a117ea

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  20 in total

Review 1.  Barriers to mucosal transmission of immunodeficiency viruses.

Authors:  Brandon F Keele; Jacob D Estes
Journal:  Blood       Date:  2011-05-09       Impact factor: 22.113

2.  Low relative abundances of the mucolytic bacterium Akkermansia muciniphila and Bifidobacterium spp. in feces of children with autism.

Authors:  Lv Wang; Claus T Christophersen; Michael J Sorich; Jacobus P Gerber; Manya T Angley; Michael A Conlon
Journal:  Appl Environ Microbiol       Date:  2011-07-22       Impact factor: 4.792

3.  Quorum Sensing Regulators Are Required for Metabolic Fitness in Vibrio parahaemolyticus.

Authors:  Sai Siddarth Kalburge; Megan R Carpenter; Sharon Rozovsky; E Fidelma Boyd
Journal:  Infect Immun       Date:  2017-02-23       Impact factor: 3.441

4.  Intestinal Microbiome, Akkermansia muciniphila, and Medical Nutrition Therapy.

Authors:  Jeffrey Bland
Journal:  Integr Med (Encinitas)       Date:  2016-10

Review 5.  Optimizing nanomedicine pharmacokinetics using physiologically based pharmacokinetics modelling.

Authors:  Darren Michael Moss; Marco Siccardi
Journal:  Br J Pharmacol       Date:  2014-07-02       Impact factor: 8.739

6.  Modeling the interactions of bacteria and Toll-like receptor-mediated inflammation in necrotizing enterocolitis.

Authors:  Julia Arciero; G Bard Ermentrout; Richard Siggers; Amin Afrazi; David Hackam; Yoram Vodovotz; Jonathan Rubin
Journal:  J Theor Biol       Date:  2012-12-10       Impact factor: 2.691

Review 7.  Efficient responses to host and bacterial signals during Vibrio cholerae colonization.

Authors:  Francesca P Rothenbacher; Jun Zhu
Journal:  Gut Microbes       Date:  2013-10-31

Review 8.  Intestinal epithelial cells and their role in innate mucosal immunity.

Authors:  A L Maldonado-Contreras; Beth A McCormick
Journal:  Cell Tissue Res       Date:  2010-11-23       Impact factor: 5.249

9.  Maternal deprivation alters epithelial secretory cell lineages in rat duodenum: role of CRF-related peptides.

Authors:  M Estienne; J Claustre; G Clain-Gardechaux; A Paquet; Y Taché; J Fioramonti; P Plaisancié
Journal:  Gut       Date:  2010-06       Impact factor: 23.059

10.  Haemophilus influenzae biofilm formation in chronic otitis media with effusion.

Authors:  Helen Van Hoecke; Ann-Sophie De Paepe; Edward Lambert; Jonas D Van Belleghem; Piet Cools; Leen Van Simaey; Pieter Deschaght; Mario Vaneechoutte; Ingeborg Dhooge
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-03-05       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.